This post is from a suggested group
INDIA API: Driving a New Era of Pharmaceutical Self-Reliance
India’s Active Pharmaceutical Ingredient (API) ecosystem has entered a transformative phase, shaped by innovation, quality-focused manufacturing, and a resolve for self-reliance. APIs form the backbone of every medicine, and India’s expanding capability in this domain has positioned the country as a vital pillar in the global pharmaceutical landscape. The journey of India’s API sector reflects a blend of scientific progress, strong policy initiatives, and industrial agility that continues to strengthen the nation’s healthcare foundation.
Over the years, Indian drug manufacturers have steadily upgraded their production infrastructure, enabling them to produce complex APIs with improved purity, stability, and therapeutic efficiency. This evolution has been supported by the rise of state-of-the-art manufacturing parks, enhanced adherence to global regulatory standards, and the growing expertise of skilled chemists and engineers. Today, India stands recognized for high-quality API production that supports both domestic pharmaceutical needs and…